Article
Rifamycin Resistance in Clostridium difficile Is Generally Associated with a Low Fitness Burden.
Antimicrobial agents and chemotherapy - 1 Sept 2016
Dang Uyen T, Zamora Idalia, Hevener Kirk E, Adhikari Sudip, Wu Xiaoqian, Hurdle Julian G
Abstract excerpt
We characterized clinically occurring and novel mutations in the β subunit of RNA polymerase in Clostridium difficile (CdRpoB), conferring rifamycin (including rifaximin) resistance. The Arg505Lys substitution did not impose an in vitro fitness cost, which may be one reason for its dominance among rifamycin-resistant clinical isolates. These observations were supported through the structural modeling of CdRpoB....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
